February 2016 Issue of Renal And Urology News
Renal & Urology News Jan-Feb 2016 Issue
Nephrology Cover Articles
It has a stronger association with future end-stage renal disease risk than past eGFR decline, large study shows.
Just over half of kidneys from deceased ECD/DCD donors are not used, study finds.
In a prospective study, prediabetes was an independent risk factor for hyperfiltration and increased albuminuria.
Urology Cover Articles
In large observational study, regular use—defined as 3 tablets per week—was associated with a 24% lower risk of dying from prostate cancer.
Patients who underwent upfront cytoreductive nephrectomy lived 6.4 months longer than those treated with upfront targeted therapy, a study found.
A combination of exercise and a flavonoid-rich diet can reduce the risk of erectile dysfunction by 21%.
Benjamin T Ristau, MD, and Robert G. Uzzo, MD, FACS, examine why adjuvant therapies have been so ineffective.
News in Brief
Among patients with stage 3 chronic kidney disease, hyperkalemia prevalence is significantly higher among diabetic than non-diabetics.
Study reveals no significant differences in hospital readmission rates and overall, cancer-specific, and recurrence-free survival rates.
True prevalence of hypospadias and related trends are difficult to estimate.
Statin users had 30% increased odds of acute kidney injury and 36% increased odds of chronic kidney disease compared with non-users.
Prostatic arterial embolization significantly reduced volumes of median lobes, central zones, peripheral zones, and whole prostate glands.
SWL treatment success rate was 70.4% and 53.1% for stones less than 15 mm and 15 mm or larger, respectively.
At the highest level, the ratings can be used to categorize facilities. They can also indicate which facilities may need more resources.
In a pilot study, an arginine-enriched drink improved postoperative immune response and infection rate.
Meta-analysis reveals a lower risk of bleeding and arterial thromboembolism compared with conventional agents.
The estimated potential staff time savings totaled 23 hours for an average facility with 70 patients, researchers found.
The death risk decreases 23% with each 33% increase in plant protein to total protein ratio, study finds.
In white men, the condition is associated with an increased risk of prostate cancer only in the absence of histologic inflammation.
Direct oral anticoagulants were superior to dose-adjusted warfarin, however, reducing the risk of major bleeding by 19% in patients with mild to moderate renal impairment.
Blacks undergoing PD or home HD and Hispanics undergoing PD are less likely than their white counterparts to receive a kidney transplant.
Lower patient-reported mental health was statistically associated with an increased incidence of high-grade complications after radical cystectomy.
Even surgery patients with stage 1 AKI without true organ damage had a 43% increase in cardiovascular mortality risk within 10 years compared with patients ...
The risk is 67% higher in men with a prostate size of 40.1-80 mL than those with smaller glands.
Even mild AKI with rapid recovery is associated with increased risk of chronic kidney disease stage 3 or higher.
In a small study, high-dose testosterone given intermittently with androgen deprivation therapy lowered PSA levels without serious adverse effects.
Researchers observed a trend toward longer time on drug among men with castration-resistant prostate cancer.
Non-users of 5-alpha-reductase inhibitors had a nearly 2.6 times increased risk of pathologic progression than those who took the drugs.
Through diet and exercise, prostate cancer patients can decrease their risk of dying from their illness.
Regular use of non-steroidal anti-inflammatory drugs for 10 years or more increased the risk of dying from renal cell carcinoma nearly 4-fold.
Increased left ventricular mass found in donors with even mild decreases in renal function.
Older age and a second episode of urinary tract infection identified as risk factors.
Results of some urine and blood tests are unlikely to affect diagnosis or management of acute kidney injury.
Enzalutamide reduced the risk of disease progression by 56% in mCRPC patients.
Use of oral megestrol acetate (MA) is associate with significant adverse effects.
Renal and Urology News Articles
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)